
argenx
Platform for antibody lead choice that supports the discovery of human antibody therapeutics.
Enterprise value
$39.4b
Share price
$704.07 ARGX
Company register number
Recent deals
Authorizing premium user...
Platform for antibody lead choice that supports the discovery of human antibody therapeutics.